Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | HPN217 |
Trade Name | |
Synonyms | HPN-217|TriTAC HPN 217|Anti-BCMA/CD3e TriTAC HPN217 |
Drug Descriptions |
HPN217 is a tri-specific molecule that targets BCMA (TNFRSF17) and CD3 epsilon domain (CD3e), as well as human serum albumin, which potentially results in activation of T-cell response and increased death of BCMA-expressing tumor cells (Blood (2018) 132 (Supplement 1): 3225). |
DrugClasses | CD3 Antibody 99 TNFRSF17 Antibody 20 |
CAS Registry Number | NA |
NCIT ID | C171631 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
HPN217 | HPN217 | 0 | 1 |